In addition, from a big perspective, medical reform is good news for hospitals, ordinary people and pharmaceutical companies. Just look at the medical reform abroad: the United States, Japan and the European Union have all tried medical reform, and the medical expenses have never dropped. Therefore, medical reform means more opportunities, and the key is whether you can read the policy;
More specifically, the pilot cities are the problem that drugs cannot be raised in price. In this case, the more direct problem is that when choosing drugs, hospitals should pay more attention to the true value of drugs, rather than the sales profits it brings. (Not to mention the gray income). Therefore, it is a good thing for a good product.